InvestorsHub Logo
Replies to #86175 on Biotech Values

AlpineBV_Miller

11/16/09 1:59 AM

#86339 RE: rkrw #86175

Anyone following the Introgen story closely would say the same thing. They actually claimed in SEC filings they had a SPA on their Advexin trials. This was false, as I got them to admit on a conference call (the last call where they took my questions).

One more instance of the SEC and NASD asleep at the switch.